These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 23888)

  • 21. Characterization of central alpha-adrenoceptors using 3H-clonidine and its derivatives.
    Jarrott B; Louis WJ; Summers RJ
    Chest; 1983 Feb; 83(2 Suppl):339-40. PubMed ID: 6129948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.
    Limbird LE; Speck JL; Smith SK
    Mol Pharmacol; 1982 May; 21(3):609-17. PubMed ID: 6125876
    [No Abstract]   [Full Text] [Related]  

  • 23. Guanyl nucleotide influences on 3H-ligand binding to alpha-noradrenergic receptors in calf brain membranes.
    U'Prichard DC; Snyder SH
    J Biol Chem; 1978 May; 253(10):3444-52. PubMed ID: 25888
    [No Abstract]   [Full Text] [Related]  

  • 24. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.
    U'Prichard DC; Greenberg DA; Snyder SH
    Mol Pharmacol; 1977 May; 13(3):454-73. PubMed ID: 17827
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine.
    U'Prichard DC; Bechtel WD; Rouot BM; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):47-60. PubMed ID: 39248
    [No Abstract]   [Full Text] [Related]  

  • 26. alpha-Noradrenergic receptors in the brain: differential effects of sodium on binding of [3H]agonists and [3H]antagonists.
    Greenberg DA; U'Prichard DC; Sheehan P; Snyder SH
    Brain Res; 1978 Jan; 140(2):378-84. PubMed ID: 23888
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacology and biochemistry of noradrenergic receptors.
    Langer SZ; Pimoule C
    Br J Dermatol; 1982 Nov; 107 Suppl 23():147-53. PubMed ID: 6128022
    [No Abstract]   [Full Text] [Related]  

  • 28. Subclassification of alpha-adrenergic receptors by direct binding studies.
    Wood CL; Arnett CD; Clarke WR; Tsai BS; Lefkowitz RJ
    Biochem Pharmacol; 1979 Apr; 28(8):1277-82. PubMed ID: 36095
    [No Abstract]   [Full Text] [Related]  

  • 29. Central alpha-adrenergic systems as targets for hypotensive drugs.
    Kobinger
    Rev Physiol Biochem Pharmacol; 1978; 81():39-100. PubMed ID: 25484
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical characteristics and regulation of brain alpha 2-adrenoceptors.
    U'Prichard DC
    Ann N Y Acad Sci; 1984; 430():55-75. PubMed ID: 6146284
    [No Abstract]   [Full Text] [Related]  

  • 31. The in silico insights of alpha-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models.
    Carrieri A; Fano A
    Curr Top Med Chem; 2007; 7(2):195-205. PubMed ID: 17266606
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.